ivabradine rowex 7.5 mg film-coated tablets
rowex ltd - ivabradine - film-coated tablet - 7.5 milligram(s) - other cardiac preparations; ivabradine
ivabradine jensonr
jensonr+ limited - ivabradine hydrochloride - angina pectoris; heart failure - cardiac therapy - symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. ivabradine is indicated: - in adults unable to tolerate or with a contra-indication to the use of beta-blockers - or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose. treatment of chronic heart failure ivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.,
ivabradine 5 mg film-coated tablets
actavis group ptc ehf - ivabradine - film-coated tablet - 5 milligram(s) - other cardiac preparations; ivabradine
ivabradine 7.5 mg film-coated tablets
actavis group ptc ehf - ivabradine - film-coated tablet - 7.5 milligram(s) - other cardiac preparations; ivabradine
ranexa 500mg modified-release tablets
a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 500mg
ranexa 375mg modified-release tablets
a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 375mg
ranexa 750mg modified-release tablets
a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 750mg
adenosine 6mg/2ml solution for injection vials
advanz pharma - adenosine - solution for injection - 3mg/1ml
adenosine 30mg/10ml solution for infusion vials
advanz pharma - adenosine - solution for infusion - 3mg/1ml
vastarel 20 mg film-coated tablets
les laboratoires servier - trimetazidine dihydrochloride - film-coated tablet - 20 milligram(s) - other cardiac preparations; trimetazidine